The range of possible chromium III applications in medicine - the short review
DOI:
https://doi.org/10.12775/JEHS.2020.10.08.033Keywords
chromium supplementation, trace element, Alzheimer’s diseases, type 2 diabetes, polycystic ovary syndromeAbstract
Introduction: The key importance of chromium III in many physiological processes of human body, its influence on insulin regulation and glucose metabolism became an indicator to make an attempt to apply chromium III supplementation in disorders treatment. Mostly because diseases such as Alzheimer’s diseases, type 2 diabetes or polycystic ovary syndrome are caused by disorders of this process.
Objective: The aim of this review was to present currently available knowledge on online database PubMed about an application, effectivity and the range of possible chromium III supplementation in medicine.
Abbreviated description of the state of knowledge: Knowledge on the subject of the function of chromium III is constantly widening. Up to the year 2014 chromium was thought to be the very necessary root responsible for appropriate functioning of human body. Nowadays, the essential role of chromium III is questionated. It is the result of the lack of sufficient manifestation of chromium deficiency in humans and animals. The recent clinical trials have been distinctly indicated that the impact of chromium III should be considered rather as a pharmacological activity than an essential trace element for humans.
Conclusions: The possible ways of chromium III supplementation in treatment of many marjory society diseases are still being searched. The recent clinical trials provided evidence both in favor and against the effectiveness and validity of chromium III supplementation. Studies finished with success are very promising but there is still a need for more updated researches.
References
Hamilton EM, Young SD, Bailey EH, Watts MJ. Chromium speciation in foodstuffs: A review. Food Chem. 2018;250:105-112.
Barbara Brodziak-Dopiera, Jerzy Kwapuliski, Krzysztof Sobczyk, Danuta Wiechua. Chromium Content in the Human Hip Joint Tissues[J]. Biomedical and Environmental Sciences, 2015, 28(2): 89-96.
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press, Washington, DC, 2001.
European Food Safety Authority. Scientific opinion on dietary reference values for chromium. EFSA J 2014;12:3845.
Vincent JB. New Evidence against Chromium as an Essential Trace Element. J Nutr. 2017;147(12):2212-2219. doi:10.3945/jn.117.255901]. [Di Bona KR, Love S, Rhodes NR, et al. Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet. J Biol Inorg Chem. 2011;16(3):381-390.
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes [published correction appears in Lancet. 2017 Jun 3;389(10085):2192]. Lancet. 2017;389(10085):2239-2251.
Guimarães MM, Carvalho AC, Silva MS. Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry. J Trace Elem Med Biol. 2016;36:65-72.
Chen G, Liu P, Pattar GR, et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol. 2006;20(4):857-870.
Barceloux DG. Chromium. J Toxicol Clin Toxicol. 1999;37(2):173-194.
Yanni AE, Stamataki NS, Konstantopoulos P, et al. Controlling type-2 diabetes by inclusion of Cr-enriched yeast bread in the daily dietary pattern: a randomized clinical trial. Eur J Nutr. 2018;57(1):259-267.
Paiva AN, Lima JG, Medeiros AC, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study. J Trace Elem Med Biol. 2015;32:66-72.
Guimarães MM, Carvalho AC, Silva MS. Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry. J Trace Elem Med Biol. 2016;36:65-72.
Weller J, Budson A. Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res. 2018;7:F1000 Faculty Rev-1161. Published 2018 Jul 31.
Soria Lopez JA, González HM, Léger GC. Alzheimer's disease. Handb Clin Neurol. 2019;167:231-255.
Boccardi V, Murasecco I, Mecocci P. Diabetes drugs in the fight against Alzheimer's disease. Ageing Res Rev. 2019;54:100936.
Krikorian R, Eliassen JC, Boespflug EL, Nash TA, Shidler MD. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr Neurosci. 2010;13(3):116-122.
Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway. Inflammopharmacology. 2020;28(2):385-400.
Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40(1):1-8.
Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS. Best Pract Res Clin Endocrinol Metab. 2018;32(3):271-281.
Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40(1):1-8.
Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A. The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2016;172(1):72-78.
Jamilian M, Foroozanfard F, Kavossian E, et al. Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2020;193(2):334-341.
Ashoush S, Abou-Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial. J Obstet Gynaecol Res. 2016;42(3):279-285.
Tang XL, Sun Z, Gong L. Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis. J Obstet Gynaecol Res. 2018;44(1):134-143.
Piotrowska A, Pilch W, Czerwińska-Ledwig O, et al. The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome. Biol Trace Elem Res. 2019;192(2):91-97.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 532
Number of citations: 0
